Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions.

Pharmacogenomics - 1 Jan 2024

Chastagner Dorian, Arnion Hélène, Danthu Clément, Touré Fatouma, Picard Nicolas

Abstract excerpt

Posttransplantation diabetes mellitus (PTDM) is a form of diabetes developed after solid organ or stem cell transplantation. This condition shares physiopathological traits with type 2 diabetes, including insulin resistance and β-cells dysfunction and its prevalence varies significantly based on the diagnostic criteria used. Immunosuppressive drugs directly contribute to PTDM risk through intricate impacts on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Immunosuppressive Agents

Share to Organ Transplantation

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 40017426
DOI: 10.1080/14622416.2025.2470613
PMCID: PMC11901360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions.PMID 40017426Read ↗

Pharmacogenetics of posttransplant diabetes mellitus.Semantic proximity Read ↗

Unveiling Diabetes: Categories, Genetics, Diagnostics, Treatments, and Future Horizons.Semantic proximity Read ↗

Multifaceted therapeutic approaches for a multigenic disease.Semantic proximity Read ↗

Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.Semantic proximity Read ↗

Risk factors and primary prevention trials for type 1 diabetes.Semantic proximity Read ↗

Type 1 diabetes.Semantic proximity Read ↗

Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research.Semantic proximity Read ↗

Type 1 diabetes mellitus: etiology, presentation, and management.Semantic proximity Read ↗

The genetic basis of diabetes mellitus.Semantic proximity Read ↗

Global risk factors, epidemiology, and disease burden of type 2 diabetes.Semantic proximity Read ↗

Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment.Semantic proximity Read ↗

In-Silico Study of the Immune Systems Associated Genes in Case of Type-2 Diabetes with Insulin Action and Resistance and in ObesitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.